Market Tracker

07/25 6:05pm ET

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

During the Trading Day
1.55 -0.03 / -1.90%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.56 +0.01 / +0.65%
 
Volume: 16.7K

Today’s Trading

Previous close1.58
Today’s open1.57
Day’s range1.55 - 1.60
Volume717,882
Average volume (3 months)1,231,566
Market cap$283.2M
Dividend yield--
Data as of 3:59pm ET, 07/25/2014

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales12.55
Price/Book4.17

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...-0.27-1.60%
TTPHTetraphase Pharmaceu...-0.26-2.38%
SCMPSucampo Pharmaceutic...-0.08-1.28%
IGIGI Laboratories Inc-0.26-4.68%
Data as of 4:00pm ET, 07/25/2014

Financials

Next reporting dateSeptember 8, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
Chief Financial Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts